Search bioRxiv⌕ Search

Biology subjects

Prodanov, D.

Publications and source records attributed to Prodanov, D..

2 recordsLinked to original sources

Making Biorisk Measurable: A Bayesian Framework for Laboratory Risk Management

Biosafety risk assessment traditionally relies on categorical scales embodied by the four WHO Risk Groups and biocontainment levels. Mapping such categories to quantitative metrics is an open problem for the field: the classifications are too coarse for operational decision-making, yet strictly probabilistic language remains inaccessible to most safety professionals, laboratory managers, and decision-makers. To bridge these gaps, the present work develops a quantitative Bayesian framework for laboratory risk management that combines WHO Risk Group classification as a prior with a Markov chain model of the incident-disaster escalation chain. Risk is reported on a log-risk scale that transforms multiplicative probabilities into additive quantities, mirroring the decibel scale in acoustics. The framework accommodates longitudinal updating with local incident data and quantifies the separate contributions of training, preventive maintenance, and inspection to system-level safety. Optionally, resource allocation recommendations providing auditable, evidence-based prioritisation can be issued. The framework is illustrated on synthetic BSL-3 scenarios and shifts the perspective of biorisk governance from static compliance assessment to dynamic risk and resource management.

bioinformatics↗

Preliminary Minimum Reporting Requirements for Reporting In-Vivo Neural Interface Research: I. Implantable Neural Interfaces

The pace of research and development in neuroscience, neurotechnology, and neurorehabilitation is rapidly accelerating, with the number of publications doubling every 4.2 years. Maintaining this progress requires technological standards and scientific reporting guidelines to provide frameworks for communication and interoperability. The present lack of such standards for neurotechnologies limits the transparency, reproducibility, and meta-analysis of this growing body of research, posing an ongoing barrier to research, clinical, and commercial objectives. Continued neurotechnological innovation requires the development of some minimal standards to promote integration between this broad spectrum of technologies and therapies. To preserve design freedom and accelerate the translation of research into safe and effective technologies with maximal user benefit, such standards must be collaboratively co-developed by a full spectrum of neuroscience and neurotechnology stakeholders. This paper summarizes the preliminary recommendations of IEEE Working Group P2794, developing a Reporting Standard for in-vivo Neural Interface Research (RSNIR). Impact StatementThis work provides a preliminary set of reporting guidelines for implantable neural interface research, developed by IEEE WG P2794 in open collaboration between a range of stakeholders to accelerate the research, development, and integration of innovative neurotechnologies.

bioengineering↗